πŸ›’ Your Cart

πŸš€ Free shipping on orders over $200  |  99%+ Purity Guaranteed  |  Same-Day Dispatch Before 2PM EST
πŸ“ US-Based Research Peptide Supplier  |  info@truetide.com
πŸ”₯ Metabolic & Fat Loss CAS: 1073485-20-7 βœ“ 99%+ Purity

5-Amino-1MQ
NNMT Inhibitor β€” Metabolic Research

β˜…β˜…β˜…β˜…β˜…4.8 / 5  Β·  Emerging NNMT inhibitor for obesity research

Select Size

$89
50mg vial
βœ“
99%+ purity, independently verified by HPLC & mass spectrometry
❄
Lyophilized vials β€” shipped with cold pack, stable at βˆ’20Β°C long term
πŸ“„
Certificate of Analysis included with every order
🚚
Same-day dispatch on orders before 2PM EST
πŸ”’
Discreet, unmarked packaging β€” research-grade handling
⚠️ For Research Use Only. 5-Amino-1MQ is not approved for human consumption or therapeutic use. This product is sold exclusively as a research chemical for in vitro and laboratory research only.

What is 5-Amino-1MQ?

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) β€” an enzyme that methylates nicotinamide (niacin), consuming S-adenosyl methionine (SAM) in the process. By inhibiting NNMT, 5-Amino-1MQ raises NAD+ precursor availability and alters fat cell metabolism, making it a research tool for obesity, adipogenesis, and metabolic syndrome studies.

CAS 1073485-20-7 | MW 192.2 Da

NNMT Inhibition

Blocks nicotinamide N-methyltransferase, preventing conversion of NAM to MNA and increasing NAD+ precursor (NAM) availability in adipocytes.

Adipogenesis Suppression

NNMT inhibition reduces PPAR-Ξ³-driven adipocyte differentiation and decreases lipid accumulation in 3T3-L1 preadipocyte research models.

SAM Conservation

Reducing NNMT activity conserves SAM for methylation reactions, altering epigenetic methylation patterns in fat tissue.

NAD+ Pathway

Elevated NAM availability increases SIRT1 activation via NAD+ β€” connecting NNMT inhibition to longevity and mitochondrial research.

Adipocyte Size Reduction

Parsons et al. (2016) demonstrated that 5-Amino-1MQ reduced fat cell size by up to 30% in isolated adipocytes and attenuated diet-induced obesity in mouse models without toxicity.

Cell Chem Biol. 2016;23(4):543–554

Metabolic Rate Enhancement

NNMT knockout and inhibition studies both show increased energy expenditure and reduced adiposity, confirming 5-Amino-1MQ mechanism in metabolic research.

Science. 2014;343(6177):1296–1300

NNMT Expression in Obesity

Elevated NNMT in white adipose tissue of obese humans correlates with metabolic dysfunction β€” establishing NNMT as a validated obesity research target for 5-Amino-1MQ studies.

Nat Commun. 2015;6:6745

Research Dosing Protocols

Murine studies: 10–40 mg/kg/day orally. In vitro adipocyte studies: 1–50 Β΅M. Endpoints include lipid staining (Oil Red O), adipocyte diameter measurement, NNMT enzymatic assay, SAM/SAH ratio, and NAM levels. Often studied alongside NAD+ supplementation for comprehensive metabolic pathway research.

Note: 5-Amino-1MQ is a small molecule (MW 192), not a peptide. Dissolves readily in DMSO for in vitro work; oral gavage for in vivo protocols.
Full Name5-Amino-1-methylquinolinium (5-Amino-1MQ)
CAS Number1073485-20-7
Molecular FormulaC₁₀H₁₀Nβ‚‚
Molecular Weight192.2 Da
TargetNNMT (nicotinamide N-methyltransferase)
Purityβ‰₯99% by HPLC
AppearanceOff-white crystalline powder
Storageβˆ’20Β°C, desiccated